This post is from a suggested group
Anti-VEGF therapy has emerged as a cornerstone in modern medicine, particularly in the treatment of diseases driven by abnormal blood vessel growth. Vascular Endothelial Growth Factor (VEGF) is a protein responsible for stimulating the formation of new blood vessels, a process known as angiogenesis. While this function is essential for normal healing and development, excessive VEGF activity can contribute to serious health conditions, making Anti-VEGF treatments highly valuable in clinical practice.
Anti-VEGF drugs work by inhibiting the action of VEGF, effectively slowing or stopping the growth of new, abnormal blood vessels. This mechanism is especially important in conditions where uncontrolled angiogenesis leads to disease progression. One of the most prominent areas where Anti-VEGF therapy is used is in ophthalmology. Diseases such as age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusion are all associated with abnormal blood vessel growth in the eye. By blocking VEGF, these treatments help reduce…